DFX Intelligence
Data Factory
Reading the graph
Reading the graph
advised by REDMILE GROUP
Delaware, United States
Data as of (this record's last observation) from federal regulator filings. Page built and rebuilt at most every 15 minutes.
| Filed | GAV | Owners | Minimum | Adviser owns | Audited | Name as filed |
|---|---|---|---|---|---|---|
| Jul 3, 2024 | $828M | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 28, 2024 | $828M | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| May 5, 2023 | $779M | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 31, 2023 | $779M | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Aug 15, 2022 | $1.1B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| May 6, 2022 | $1.1B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 31, 2022 | $1.1B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Feb 9, 2022 | $1.4B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Dec 2, 2021 | $1.4B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 31, 2021 | $1.4B | 138 | $5.0M | 700.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Feb 26, 2021 | $674M | 102 | $5.0M | 800.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Aug 27, 2020 | $674M | 102 | $5.0M | 800.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 30, 2020 | $674M | 102 | $5.0M | 800.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Mar 29, 2019 | $0 | 27 | $5.0M | 100.0% | yes | REDMILE BIOPHARMA INVESTMENTS II, L.P. |
| Custodian | Legal name | City | State | Country | Related person | SEC number |
|---|---|---|---|---|---|---|
| JP MORGAN CHASE BANK | JP MORGAN CHASE BANK, N.A. | NEW YORK | New York | United States | no | n/a |
| MORGAN STANLEY & CO. LLC | MORGAN STANLEY & CO. LLC | SAN FRANCISCO | California | United States | no | 8-15869 |